中國核建(601611.SH):中核二三擬通過引進雙百基金增資10億元
格隆匯 12 月 29日丨中國核建(601611.SH)公佈,公司所屬的控股子公司中國核工業二三建設有限公司(“中核二三”或“標的公司”)擬通過引進杭州國改雙百協同股權投資合夥企業(有限合夥)(“雙百基金”)增資10億元,改善資產結構與盈利能力。
中核二三作為國企改革“雙百企業”,通過增資擴股方式引進戰略投資者是實現股權多元化的重要途徑,符合公司及中核二三的戰略發展方向和改革方向。通過此次引入雙百基金,有利於中核二三進一步優化資本結構,提高資產的流動性和靈活性;有利於中核二三體制機制創新,完善現代化企業制度、進一步激發企業活力;有利於積極發揮各自優勢,實現資源互補,強化協同合作共贏,共同打造“雙百”改革典範,夯實中核二三高質量發展基礎;也有利於公司充分利用政策紅利,把握國有企業深化改革機遇,進一步深化和推進改革工作,鞏固企業核心競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.